Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Alternativ können Sie versuchen, selbst über Ihren lokalen Bibliothekskatalog auf das gewünschte Dokument zuzugreifen.
Bei Zugriffsproblemen kontaktieren Sie uns gern.
10 Ergebnisse
Sortierung:
In: The Economic Journal, Band 83, Heft 331, S. 953
In: A journal of church and state: JCS, Band 25, Heft 3, S. 566-567
ISSN: 2040-4867
In: Carbon & climate law review: CCLR, Band 10, Heft 3, S. 239-242
ISSN: 2190-8230
In: Peace research abstracts journal, Band 44, Heft 4, S. 173-174
ISSN: 0031-3599
In: The Economic Journal, Band 83, Heft 329, S. 295
In: Carbon & climate law review: CCLR, Band 14, Heft 4, S. 294-305
ISSN: 2190-8230
FrontMatter -- Contents -- Preface -- Executive Summary -- 1 Introduction -- 2 Demographic Characteristics of the Older Workforce -- 3 The Role of the Changing Labor Market and the Changing Nature of Work in Older Workers' Work Experiences and Health Outcomes -- 4 The Social and Economic Context of Work for Older Persons -- 5 Physical and Cognitive Differences Between Older and Younger Workers -- 6 Effects of Workplace Exposures on Older Workers -- 7 Programs and Policies Related to the Older Workforce and Safe Work -- 8 Interventions for Older Workers -- 9 Conclusions and Recommendations -- References -- Appendixes -- Appendix A Epidemiological and Demographic Tables -- Appendix B Estimated Survival Functions for Men and Women -- Appendix C Biographical Sketches of Committee Members and Staff -- Index.
The Gynecologic Cancer InterGroup (GCIG) Fifth Ovarian Cancer Consensus Conference (OCCC) was held in Tokyo, Japan from 7 to 9 November 2015. It provided international consensus on 15 important questions in 4 topic areas, which were generated in accordance with the mission statement to establish 'International Consensus for Designing Better Clinical Trials'. The methodology for obtaining consensus was previously established and followed during the Fifth OCCC. All 29 clinical trial groups of GCIG participated in program development and deliberations. Draft consensus statements were discussed in topic groups as well as in a plenary forum. The final statements were then presented to all 29 member groups for voting and documentation of the level of consensus. Full consensus was obtained for 11 of the 15 statements with 28/29 groups agreeing to 3 statements, and 27/29 groups agreeing to 1 statement. The high acceptance rate of the statements among trial groups reflects the fact that we share common questions, and recognise important unmet needs that will guide future research in ovarian cancer. © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. ; Peer reviewed
BASE